Search Results - "NAKATANI, Tatsuya"

Refine Results
  1. 1

    Anti‐PD‐L1 treatment enhances antitumor effect of everolimus in a mouse model of renal cell carcinoma by Hirayama, Yukiyoshi, Gi, Min, Yamano, Shotaro, Tachibana, Hirokazu, Okuno, Takahiro, Tamada, Satoshi, Nakatani, Tatsuya, Wanibuchi, Hideki

    Published in Cancer science (01-12-2016)
    “…Immunotherapy based on blockade of the programmed death‐1 (PD‐1)/programmed death‐ligand 1 (PD‐L1) axis has shown promising clinical activity for renal cell…”
    Get full text
    Journal Article
  2. 2

    Heat shock protein 70 inhibitors suppress androgen receptor expression in LNCaP95 prostate cancer cells by Kita, Kazuaki, Shiota, Masayuki, Tanaka, Masako, Otsuka, Asuka, Matsumoto, Masaki, Kato, Minoru, Tamada, Satoshi, Iwao, Hiroshi, Miura, Katsuyuki, Nakatani, Tatsuya, Tomita, Shuhei

    Published in Cancer science (01-09-2017)
    “…Androgen deprivation therapy is initially effective for treating patients with advanced prostate cancer; however, the prostate cancer gradually becomes…”
    Get full text
    Journal Article
  3. 3

    Potential of hyperbaric oxygen in urological diseases by Tanaka, Tomoaki, Minami, Akinori, Uchida, Junji, Nakatani, Tatsuya

    Published in International journal of urology (01-09-2019)
    “…Hyperbaric oxygen therapy is a promising medical technology that delivers oxygen to targeted tissues at high pressure to increase the amount of dissolved…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Association of sarcopenia with phase angle and body mass index in kidney transplant recipients by Kosoku, Akihiro, Uchida, Junji, Nishide, Shunji, Kabei, Kazuya, Shimada, Hisao, Iwai, Tomoaki, Maeda, Keiko, Hanayama, Yoshiko, Ishihara, Takuma, Naganuma, Toshihide, Takemoto, Yoshiaki, Nakatani, Tatsuya

    Published in Scientific reports (14-01-2020)
    “…Malnutrition is an important risk factor for the development of sarcopenia. Recently, phase angle (PhA) obtained from the bioelectrical impedance analysis is…”
    Get full text
    Journal Article
  6. 6

    Latest insights on ABO‐incompatible living‐donor renal transplantation by Uchida, Junji, Kosoku, Akihiro, Naganuma, Toshihide, Tanaka, Tomoaki, Nakatani, Tatsuya

    Published in International journal of urology (01-01-2020)
    “…This review summarizes the latest insights on ABO‐incompatible living‐donor renal transplantation. Desensitization protocols and clinical outcomes were…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Prolyl-hydroxylase inhibitors reconstitute tumor blood vessels in mice by Nishide, Shunji, Uchida, Junji, Matsunaga, Shinji, Tokudome, Kentaro, Yamaguchi, Takehiro, Kabei, Kazuya, Moriya, Taiki, Miura, Katsuyuki, Nakatani, Tatsuya, Tomita, Shuhei

    Published in Journal of pharmacological sciences (01-06-2020)
    “…Tumor blood vessels have leaky and low blood flow properties, which lead to hypoxia and low nutrient levels in the tumor tissue area known as the tumor…”
    Get full text
    Journal Article
  9. 9

    Cytoplasmic Accumulation of Heterogeneous Nuclear Ribonucleoprotein K Strongly Promotes Tumor Invasion in Renal Cell Carcinoma Cells by Otoshi, Taiyo, Tanaka, Tomoaki, Morimoto, Kazuya, Nakatani, Tatsuya

    Published in PloS one (29-12-2015)
    “…Heterogeneous nuclear ribonucleoprotein (hnRNP) K is a part of the ribonucleoprotein complex which regulates diverse biological events. While overexpression of…”
    Get full text
    Journal Article
  10. 10

    Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis: The J-DAVID Randomized Clinical Trial by Shoji, Tetsuo, Inaba, Masaaki, Fukagawa, Masafumi, Ando, Ryoichi, Emoto, Masanori, Fujii, Hisako, Fujimori, Akira, Fukui, Mitsuru, Hase, Hiroki, Hashimoto, Tetsuya, Hirakata, Hideki, Honda, Hirokazu, Hosoya, Tatsuo, Ikari, Yuji, Inaguma, Daijo, Inoue, Toru, Isaka, Yoshitaka, Iseki, Kunitoshi, Ishimura, Eiji, Itami, Noritomo, Ito, Chiharu, Kakuta, Toshitaka, Kawai, Toru, Kawanishi, Hideki, Kobayashi, Shuzo, Kumagai, Junko, Maekawa, Kiyoshi, Masakane, Ikuto, Minakuchi, Jun, Mitsuiki, Koji, Mizuguchi, Takashi, Morimoto, Satoshi, Murohara, Toyoaki, Nakatani, Tatsuya, Negi, Shigeo, Nishi, Shinichi, Nishikawa, Mitsushige, Ogawa, Tetsuya, Ohta, Kazumichi, Ohtake, Takayasu, Okamura, Mikio, Okuno, Senji, Shigematsu, Takashi, Sugimoto, Toshitsugu, Suzuki, Masashi, Tahara, Hideki, Takemoto, Yoshiaki, Tanaka, Kenji, Tominaga, Yoshihiro, Tsubakihara, Yoshiharu, Tsujimoto, Yoshihiro, Tsuruya, Kazuhiko, Ueda, Shinichiro, Watanabe, Yuzo, Yamagata, Kunihiro, Yamakawa, Tomoyuki, Yano, Shozo, Yokoyama, Keitaro, Yorioka, Noriaki, Yoshiyama, Minoru, Nishizawa, Yoshiki

    “…IMPORTANCE: Patients with chronic kidney disease have impaired vitamin D activation and elevated cardiovascular risk. Observational studies in patients treated…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Selective plasma exchange in ABO-incompatible kidney transplantation: comparison of substitution with albumin and partial substitution with fresh frozen plasma by Hanaoka, Ako, Naganuma, Toshihide, Kabata, Daijiro, Takemoto, Yoshiaki, Uchida, Junji, Nakatani, Tatsuya, Shintani, Ayumi

    Published in Scientific reports (29-01-2020)
    “…We have performed selective plasma exchange (SePE) as apheresis before ABO-incompatible kidney transplantation since 2015. In this study, we divided the SePE…”
    Get full text
    Journal Article
  13. 13

    Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: study protocol for a multicenter randomized phase II trial (the OCUU-CRPC study) by Iguchi, Taro, Tamada, Satoshi, Kato, Minoru, Yasuda, Sayaka, Yamasaki, Takeshi, Nakatani, Tatsuya

    Published in BMC cancer (11-04-2019)
    “…Enzalutamide is an oral androgen receptor targeted agent that has been shown to improve survival in PREVAIL trials and has been approved for patients with…”
    Get full text
    Journal Article
  14. 14

    Involvement of estrogen receptors in prostatic diseases by Kawashima, Hidenori, Nakatani, Tatsuya

    Published in International journal of urology (01-06-2012)
    “…Accumulating evidence shows that estrogens participate in the pathogenesis and development of benign prostatic hyperplasia and prostate cancer by activating…”
    Get full text
    Journal Article
  15. 15

    Phase I/II study of multipeptide cancer vaccine IMA901 after single‐dose cyclophosphamide in Japanese patients with advanced renal cell cancer with long‐term follow up by Hongo, Fumiya, Ueda, Takashi, Takaha, Natsuki, Tamada, Satoshi, Nakatani, Tatsuya, Miki, Tsuneharu, Ukimura, Osamu

    Published in International journal of urology (01-02-2023)
    “…Background IMA901 is the first therapeutic vaccine for renal cell cancer (RCC). It contains multiple tumor‐associated peptides (TUMAPs) that are naturally…”
    Get full text
    Journal Article
  16. 16

    U-shaped relationship between serum uric acid levels and intrarenal hemodynamic parameters in healthy subjects by Uedono, Hideki, Tsuda, Akihiro, Ishimura, Eiji, Nakatani, Shinya, Kurajoh, Masafumi, Mori, Katsuhito, Uchida, Junji, Emoto, Masanori, Nakatani, Tatsuya, Inaba, Masaaki

    “…Hyperuricemia has been reported to affect renal hemodynamics. In a recent study, both low and high levels of serum uric acid (SUA) were found to be associated…”
    Get more information
    Journal Article
  17. 17

    Effects of Liposome Clodronate on Renal Leukocyte Populations and Renal Fibrosis in Murine Obstructive Nephropathy by Kitamoto, Koichiro, Machida, Yuichi, Uchida, Junji, Izumi, Yasukatsu, Shiota, Masayuki, Nakao, Takafumi, Iwao, Hiroshi, Yukimura, Tokihito, Nakatani, Tatsuya, Miura, Katsuyuki

    “…Although liposome-encapsulated clodronate has been used as a means to deplete macrophages from certain tissues, target leukocyte subtypes within the kidney are…”
    Get full text
    Journal Article
  18. 18

    Cerebral Microbleeds Predict Intracerebral Hemorrhage in Hemodialysis Patients by Naganuma, Toshihide, Takemoto, Yoshiaki, Shoji, Tetsuo, Ishimura, Eiji, Okamura, Mikio, Nakatani, Tatsuya

    Published in Stroke (1970) (01-08-2015)
    “…BACKGROUND AND PURPOSE—In hemodialysis patients, previous reports have described a high prevalence of cerebral microbleeds (CMBs), but no longitudinal studies…”
    Get full text
    Journal Article
  19. 19

    Outcomes of indwelling metallic stents for malignant extrinsic ureteral obstruction by Asakawa, Jumpei, Iguchi, Taro, Tamada, Satoshi, Ninomiya, Noriko, Kato, Minoru, Yamasaki, Takeshi, Nakatani, Tatsuya

    Published in International journal of urology (01-03-2018)
    “…Objectives To report the treatment outcomes of patients with extrinsic ureteral obstruction treated with metallic stents and to identify the factors predicting…”
    Get full text
    Journal Article
  20. 20

    ABO-incompatible kidney transplantation as a renal replacement therapy-A single low-volume center experience in Japan by Kosoku, Akihiro, Uchida, Junji, Nishide, Shunji, Kabei, Kazuya, Shimada, Hisao, Iwai, Tomoaki, Kuwabara, Nobuyuki, Maeda, Keiko, Naganuma, Toshihide, Kumada, Norihiko, Takemoto, Yoshiaki, Ishihara, Takuma, Shintani, Ayumi, Nakatani, Tatsuya

    Published in PloS one (31-12-2018)
    “…Living donor kidney transplantation is preferable to deceased donor transplantation due to its superior long-term patient and graft survivals. However, ABO…”
    Get full text
    Journal Article